Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Kymera Therapeutics (KYMR) over the last 6 years, with Dec 2024 value amounting to $38.0 million.

  • Kymera Therapeutics' Other Non Operating Income rose 7.70% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 13.70%. This contributed to the annual value of $38.0 million for FY2024, which is 102.65% up from last year.
  • As of FY2024, Kymera Therapeutics' Other Non Operating Income stood at $38.0 million, which was up 102.65% from $18.8 million recorded in FY2023.
  • In the past 5 years, Kymera Therapeutics' Other Non Operating Income registered a high of $38.0 million during FY2024, and its lowest value of $488,000 during FY2021.
  • In the last 3 years, Kymera Therapeutics' Other Non Operating Income had a median value of $18.8 million in 2023 and averaged $21.1 million.
  • In the last 5 years, Kymera Therapeutics' Other Non Operating Income plummeted by 40.92% in 2021 and then surged by 1,257.38% in 2022.
  • Kymera Therapeutics' Other Non Operating Income (Yearly) stood at $826,000 in 2020, then crashed by 40.92% to $488,000 in 2021, then surged by 1,257.38% to $6.6 million in 2022, then surged by 183.27% to $18.8 million in 2023, then surged by 102.65% to $38.0 million in 2024.